Chalmers University of Technology   Report issue

Academic/Hospital Phase 1
Founded: Gothenburg Sweden (1829)

Organization Overview

First Clinical Trial
2018
NCT03838822
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Chalmers University of Technology

Active Ingredients

Drugs in Phase 1 Trials (3)

acetylcysteine (mucomyst) (1 trial)

levocarnitine (carnitor) (1 trial)

nicotinamide (1 trial)

Drugs in Other Trials (4)

beta-glucans (1 trial)

bilberry (1 trial)

gluten (1 trial)

oat (1 trial)

Indications

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 7